Clinical Trials
Participating in Mount Sinai’s clinical trials allows you to take advantage of innovative treatments as we work together to advance the future of medicine.
|
| ||||
View All Service AreasDiscover how The Mount Sinai Medical Center can offer you the most advanced and compassionate inpatient and outpatient care. Institutes, Centers, Programs and LaboratoriesThe Mount Sinai Medical Center is home to an extensive array of top-notch research centers and laboratories, where scientists and researchers work to translate the rapid advances in basic science into the innovative patient care for which we are known. |
Hepatitis C StudyA Multicenter, randomized, open-label, controlled study of the effect of treatment with once weekly Pegasys plus daily Copegus with or without concomitant pioglitazone (Actos) on early viral kinetics in treatment-naive patients with chronic hepatitis C (genotype-1 HCV infection) and insulin resistance The purpose of this study is to see how well Pegasys, in combination with Copegus, with and without Actos, will work to treat chronic hepatitis C (CHC) and insulin resistance. All of the drugs being administered are approved by the Food and Drug Administration (FDA). The study itself will last about 77 to 93 weeks and involves up to 16 or 20 study visits to the clinic depending to which study group you are assigned.
|
Coming to Mount Sinai?DirectionsArrive at the Medical Center by car, public transportation and from all area airports. Find A Faculty MemberEventsSearch for EventsMount Sinai has scheduled events for faculty, physicians, students, staff, and the community. View events by day, week, and month. | |
